The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Artificial Blood Market Research Report 2025
Synopsis
Artificial blood, also known as synthetic blood or blood substitute, refers to a substance designed to mimic the oxygen-carrying properties of natural blood. It is used in medical emergencies when natural blood is unavailable.
The global Artificial Blood market was valued at US$ 3042.6 million in 2023 and is anticipated to reach US$ 6771.3 million by 2030, witnessing a CAGR of 11.6% during the forecast period 2024-2030.
The development of safe and effective artificial blood is an ongoing area of research. It has the potential to address critical shortages in blood supply for medical transfusions.
This report aims to provide a comprehensive presentation of the global market for Artificial Blood, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Blood.
Report Scope
The Artificial Blood market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Artificial Blood market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Blood companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Aurum Biosciences Ltd.
HEMARINA SA
HbO2 Therapeutics
KaloCyte Inc.
SpheriTech Ltd.
NuvOx Pharma
Segment by Type
Human Blood
Synthetic Blood
Animal Blood
Segment by Application
Hemoglobin-Based Oxygen Carriers (HBOCs)
Perflurocarbon Emulsions (PFCEs)
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Artificial Blood companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Artificial blood, also known as synthetic blood or blood substitute, refers to a substance designed to mimic the oxygen-carrying properties of natural blood. It is used in medical emergencies when natural blood is unavailable.
The global Artificial Blood market was valued at US$ 3042.6 million in 2023 and is anticipated to reach US$ 6771.3 million by 2030, witnessing a CAGR of 11.6% during the forecast period 2024-2030.
The development of safe and effective artificial blood is an ongoing area of research. It has the potential to address critical shortages in blood supply for medical transfusions.
This report aims to provide a comprehensive presentation of the global market for Artificial Blood, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Blood.
Report Scope
The Artificial Blood market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Artificial Blood market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Blood companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Aurum Biosciences Ltd.
HEMARINA SA
HbO2 Therapeutics
KaloCyte Inc.
SpheriTech Ltd.
NuvOx Pharma
Segment by Type
Human Blood
Synthetic Blood
Animal Blood
Segment by Application
Hemoglobin-Based Oxygen Carriers (HBOCs)
Perflurocarbon Emulsions (PFCEs)
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Artificial Blood companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artificial Blood Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Human Blood
1.2.3 Synthetic Blood
1.2.4 Animal Blood
1.3 Market by Application
1.3.1 Global Artificial Blood Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hemoglobin-Based Oxygen Carriers (HBOCs)
1.3.3 Perflurocarbon Emulsions (PFCEs)
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Artificial Blood Market Perspective (2019-2030)
2.2 Artificial Blood Growth Trends by Region
2.2.1 Global Artificial Blood Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Artificial Blood Historic Market Size by Region (2019-2024)
2.2.3 Artificial Blood Forecasted Market Size by Region (2025-2030)
2.3 Artificial Blood Market Dynamics
2.3.1 Artificial Blood Industry Trends
2.3.2 Artificial Blood Market Drivers
2.3.3 Artificial Blood Market Challenges
2.3.4 Artificial Blood Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Artificial Blood Players by Revenue
3.1.1 Global Top Artificial Blood Players by Revenue (2019-2024)
3.1.2 Global Artificial Blood Revenue Market Share by Players (2019-2024)
3.2 Global Artificial Blood Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Artificial Blood Revenue
3.4 Global Artificial Blood Market Concentration Ratio
3.4.1 Global Artificial Blood Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artificial Blood Revenue in 2023
3.5 Artificial Blood Key Players Head office and Area Served
3.6 Key Players Artificial Blood Product Solution and Service
3.7 Date of Enter into Artificial Blood Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Artificial Blood Breakdown Data by Type
4.1 Global Artificial Blood Historic Market Size by Type (2019-2024)
4.2 Global Artificial Blood Forecasted Market Size by Type (2025-2030)
5 Artificial Blood Breakdown Data by Application
5.1 Global Artificial Blood Historic Market Size by Application (2019-2024)
5.2 Global Artificial Blood Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Artificial Blood Market Size (2019-2030)
6.2 North America Artificial Blood Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Artificial Blood Market Size by Country (2019-2024)
6.4 North America Artificial Blood Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Artificial Blood Market Size (2019-2030)
7.2 Europe Artificial Blood Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Artificial Blood Market Size by Country (2019-2024)
7.4 Europe Artificial Blood Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Artificial Blood Market Size (2019-2030)
8.2 Asia-Pacific Artificial Blood Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Artificial Blood Market Size by Region (2019-2024)
8.4 Asia-Pacific Artificial Blood Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Artificial Blood Market Size (2019-2030)
9.2 Latin America Artificial Blood Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Artificial Blood Market Size by Country (2019-2024)
9.4 Latin America Artificial Blood Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Artificial Blood Market Size (2019-2030)
10.2 Middle East & Africa Artificial Blood Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Artificial Blood Market Size by Country (2019-2024)
10.4 Middle East & Africa Artificial Blood Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Aurum Biosciences Ltd.
11.1.1 Aurum Biosciences Ltd. Company Detail
11.1.2 Aurum Biosciences Ltd. Business Overview
11.1.3 Aurum Biosciences Ltd. Artificial Blood Introduction
11.1.4 Aurum Biosciences Ltd. Revenue in Artificial Blood Business (2019-2024)
11.1.5 Aurum Biosciences Ltd. Recent Development
11.2 HEMARINA SA
11.2.1 HEMARINA SA Company Detail
11.2.2 HEMARINA SA Business Overview
11.2.3 HEMARINA SA Artificial Blood Introduction
11.2.4 HEMARINA SA Revenue in Artificial Blood Business (2019-2024)
11.2.5 HEMARINA SA Recent Development
11.3 HbO2 Therapeutics
11.3.1 HbO2 Therapeutics Company Detail
11.3.2 HbO2 Therapeutics Business Overview
11.3.3 HbO2 Therapeutics Artificial Blood Introduction
11.3.4 HbO2 Therapeutics Revenue in Artificial Blood Business (2019-2024)
11.3.5 HbO2 Therapeutics Recent Development
11.4 KaloCyte Inc.
11.4.1 KaloCyte Inc. Company Detail
11.4.2 KaloCyte Inc. Business Overview
11.4.3 KaloCyte Inc. Artificial Blood Introduction
11.4.4 KaloCyte Inc. Revenue in Artificial Blood Business (2019-2024)
11.4.5 KaloCyte Inc. Recent Development
11.5 SpheriTech Ltd.
11.5.1 SpheriTech Ltd. Company Detail
11.5.2 SpheriTech Ltd. Business Overview
11.5.3 SpheriTech Ltd. Artificial Blood Introduction
11.5.4 SpheriTech Ltd. Revenue in Artificial Blood Business (2019-2024)
11.5.5 SpheriTech Ltd. Recent Development
11.6 NuvOx Pharma
11.6.1 NuvOx Pharma Company Detail
11.6.2 NuvOx Pharma Business Overview
11.6.3 NuvOx Pharma Artificial Blood Introduction
11.6.4 NuvOx Pharma Revenue in Artificial Blood Business (2019-2024)
11.6.5 NuvOx Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Artificial Blood Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Human Blood
Table 3. Key Players of Synthetic Blood
Table 4. Key Players of Animal Blood
Table 5. Global Artificial Blood Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Artificial Blood Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Artificial Blood Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Artificial Blood Market Share by Region (2019-2024)
Table 9. Global Artificial Blood Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Artificial Blood Market Share by Region (2025-2030)
Table 11. Artificial Blood Market Trends
Table 12. Artificial Blood Market Drivers
Table 13. Artificial Blood Market Challenges
Table 14. Artificial Blood Market Restraints
Table 15. Global Artificial Blood Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Artificial Blood Market Share by Players (2019-2024)
Table 17. Global Top Artificial Blood Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Blood as of 2023)
Table 18. Ranking of Global Top Artificial Blood Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Artificial Blood Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Artificial Blood Product Solution and Service
Table 22. Date of Enter into Artificial Blood Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Artificial Blood Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Artificial Blood Revenue Market Share by Type (2019-2024)
Table 26. Global Artificial Blood Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Artificial Blood Revenue Market Share by Type (2025-2030)
Table 28. Global Artificial Blood Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Artificial Blood Revenue Market Share by Application (2019-2024)
Table 30. Global Artificial Blood Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Artificial Blood Revenue Market Share by Application (2025-2030)
Table 32. North America Artificial Blood Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Artificial Blood Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Artificial Blood Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Artificial Blood Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Artificial Blood Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Artificial Blood Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Artificial Blood Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Artificial Blood Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Artificial Blood Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Artificial Blood Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Artificial Blood Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Artificial Blood Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Artificial Blood Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Artificial Blood Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Artificial Blood Market Size by Country (2025-2030) & (US$ Million)
Table 47. Aurum Biosciences Ltd. Company Detail
Table 48. Aurum Biosciences Ltd. Business Overview
Table 49. Aurum Biosciences Ltd. Artificial Blood Product
Table 50. Aurum Biosciences Ltd. Revenue in Artificial Blood Business (2019-2024) & (US$ Million)
Table 51. Aurum Biosciences Ltd. Recent Development
Table 52. HEMARINA SA Company Detail
Table 53. HEMARINA SA Business Overview
Table 54. HEMARINA SA Artificial Blood Product
Table 55. HEMARINA SA Revenue in Artificial Blood Business (2019-2024) & (US$ Million)
Table 56. HEMARINA SA Recent Development
Table 57. HbO2 Therapeutics Company Detail
Table 58. HbO2 Therapeutics Business Overview
Table 59. HbO2 Therapeutics Artificial Blood Product
Table 60. HbO2 Therapeutics Revenue in Artificial Blood Business (2019-2024) & (US$ Million)
Table 61. HbO2 Therapeutics Recent Development
Table 62. KaloCyte Inc. Company Detail
Table 63. KaloCyte Inc. Business Overview
Table 64. KaloCyte Inc. Artificial Blood Product
Table 65. KaloCyte Inc. Revenue in Artificial Blood Business (2019-2024) & (US$ Million)
Table 66. KaloCyte Inc. Recent Development
Table 67. SpheriTech Ltd. Company Detail
Table 68. SpheriTech Ltd. Business Overview
Table 69. SpheriTech Ltd. Artificial Blood Product
Table 70. SpheriTech Ltd. Revenue in Artificial Blood Business (2019-2024) & (US$ Million)
Table 71. SpheriTech Ltd. Recent Development
Table 72. NuvOx Pharma Company Detail
Table 73. NuvOx Pharma Business Overview
Table 74. NuvOx Pharma Artificial Blood Product
Table 75. NuvOx Pharma Revenue in Artificial Blood Business (2019-2024) & (US$ Million)
Table 76. NuvOx Pharma Recent Development
Table 77. Research Programs/Design for This Report
Table 78. Key Data Information from Secondary Sources
Table 79. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Artificial Blood Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Artificial Blood Market Share by Type: 2023 VS 2030
Figure 3. Human Blood Features
Figure 4. Synthetic Blood Features
Figure 5. Animal Blood Features
Figure 6. Global Artificial Blood Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Artificial Blood Market Share by Application: 2023 VS 2030
Figure 8. Hemoglobin-Based Oxygen Carriers (HBOCs) Case Studies
Figure 9. Perflurocarbon Emulsions (PFCEs) Case Studies
Figure 10. Artificial Blood Report Years Considered
Figure 11. Global Artificial Blood Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Artificial Blood Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Artificial Blood Market Share by Region: 2023 VS 2030
Figure 14. Global Artificial Blood Market Share by Players in 2023
Figure 15. Global Top Artificial Blood Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Blood as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Artificial Blood Revenue in 2023
Figure 17. North America Artificial Blood Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Artificial Blood Market Share by Country (2019-2030)
Figure 19. United States Artificial Blood Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Artificial Blood Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Artificial Blood Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Artificial Blood Market Share by Country (2019-2030)
Figure 23. Germany Artificial Blood Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Artificial Blood Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Artificial Blood Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Artificial Blood Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Artificial Blood Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Artificial Blood Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Artificial Blood Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Artificial Blood Market Share by Region (2019-2030)
Figure 31. China Artificial Blood Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Artificial Blood Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Artificial Blood Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Artificial Blood Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Artificial Blood Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Artificial Blood Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Artificial Blood Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Artificial Blood Market Share by Country (2019-2030)
Figure 39. Mexico Artificial Blood Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Artificial Blood Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Artificial Blood Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Artificial Blood Market Share by Country (2019-2030)
Figure 43. Turkey Artificial Blood Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Artificial Blood Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Aurum Biosciences Ltd. Revenue Growth Rate in Artificial Blood Business (2019-2024)
Figure 46. HEMARINA SA Revenue Growth Rate in Artificial Blood Business (2019-2024)
Figure 47. HbO2 Therapeutics Revenue Growth Rate in Artificial Blood Business (2019-2024)
Figure 48. KaloCyte Inc. Revenue Growth Rate in Artificial Blood Business (2019-2024)
Figure 49. SpheriTech Ltd. Revenue Growth Rate in Artificial Blood Business (2019-2024)
Figure 50. NuvOx Pharma Revenue Growth Rate in Artificial Blood Business (2019-2024)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
